| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |